Report copyright - Romosozumab Sclerostin-Inhibition in der Osteoporosetherapie€¦ · Romosozumab followed by DMAb ….reduced new vertebral, clinical, and non-vertebral fracture risk vs Pbo followed
Please pass captcha verification before submit form
Please pass captcha verification before submit form